Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Kush Gupta

1PUBLICATIONS

9CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Jan 09, 2024

2/1 dose schedule of sunitinib is superior than the 4/2 regimen for the first-line therapy of clear cell metastatic renal cell carcinoma - An Indian experience.

Jiten Jaipuria, Ankita Jain, Shashikant Gupta

Pageof 1

Frequent Collaborators

1 joint publications

Jiten Jaipuria

1 joint publications

Ankita Jain

1 joint publications

Shashikant Gupta

1 joint publications

Nripesh Sadasukhi

1 joint publications

Priyatham Kasaraneni

1 joint publications

Amitabh Singh

1 joint publications

Girish Sharma

1 joint publications

Vineet Talwar

1 joint publications

Sudhir Kumar Rawal

Frequent Collaborators

1 joint publications

Jiten Jaipuria

1 joint publications

Ankita Jain

1 joint publications

Shashikant Gupta

1 joint publications

Nripesh Sadasukhi

Top Related Videos

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

See more related videos

Top Related Videos

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

See more related videos